drugset / Trial / NCT00567983

Topical Cyclosporine and Disease Progression

NCT00567983

Phase 4 Completed 80 enrolled Innovative Medical
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.

Timeline

Start
2007-12
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclosporine Peptide Other

Indications

No indication recorded.